Galactorrhoea, hyperprolactinaemia, and pituitary adenoma presenting during metoclopramide therapy

5Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A 49-year-old woman presented with a one month history of headaches, loss of libido and galactorrhoea. She had been taking metoclopramide for the previous 3 months for reflux oesophagitis. She was found to have substantially elevated serum prolactin levels and a pituitary adenoma, which have not been previously described in a patient taking metoclopramide. The drug was stopped and the serum prolactin level fell progressively to normal with resolution of symptoms over 4 months. This suggested that contrary to our original impression that she had a prolactin-secreting pituitary adenoma which had been stimulated by metoclopramide, she had metoclopramide-induced hyperprolactinaemia and an incidental pituitary tumour. © 1982 The Fellowship of Postgraduate Medicine.

Cite

CITATION STYLE

APA

Cooper, B. T., Mountford, R. A., & McKee, C. (1982). Galactorrhoea, hyperprolactinaemia, and pituitary adenoma presenting during metoclopramide therapy. Postgraduate Medical Journal, 58(679), 314–315. https://doi.org/10.1136/pgmj.58.679.314

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free